International Atomic Energy Agency
Department of Technical Cooperation
And
Nuclear Medicine and Diagnostic Imaging Section
Division of Human Health
RAS6078
Strengthening Nuclear Medicine Applications through Education and Training toHelp Fighting Non-Communicable Diseases (ARASIA)

Workshop: Nuclear Medicine Techniques in Neurological
Diseases: Emphasis on Oncology and Neurology (ICNMP-PA)
May 23-27, 2016
Senri Life Science Center,Osaka, Japan

Local Course Director
HATAZAWA, Jun
Osaka University Graduate School of Medicine
Department of Nuclear Medicine and Tracer Kinetics
565-0871 OsakaJapan
Tel: 81668793461
Fax: 81668793469
E-mail: hatazawa@tracer.med.osaka-u.ac.jp

IAEA TECHNICAL OFFICER
Mr. PASCUAL Thomas NB
Section of Nuclear Medicine and Diagnostic Imaging
Division of Human HealthInternational Atomic Energy Agency, Vienna International Centre, PO Box
100, 1400 Vienna, Australia

IAEA PROJECT MANAGEMENT OFFICER:
Mr SHAKHASHIRO, Abdulghani
Asia and the Pacific Section 1
Division for Asia and the Pacific
Department of Technical Cooperation
M.Abdullah@iaea.org

PROGRAM
Monday 23 May 2016
09:00-09:30

Opening remarks
Pre-Course Evaluation

Pascual, Thomas(Technical Officer,IAEA)
Shakhashiro,Abdulghani(IAEA ProgrammeManagement Officer)
Prof. Jun Hatazawa
Course Director

SESSION 1
Chair
GIESEL, Frederik
University Hospital Heidelberg
Department of Nuclear Medicine Clinic of Radiology
69120 Heidelberg
Germany
Pascual, Thomas (Technical Officer, IAEA)
Instrumentation of SPECT and PET
09:30- 10:30
ILO: Review and discuss the importance of Instrumentations
used in SPECT and PET for Neurological Imaging using Nuclear
Medicine techniques

10:30-11:30

Handling computer software, modeling, and image analysis
ILO: Review and discuss the importance of Handlingcomputer software, modeling, and image analysis forNeurological Imaging using Nuclear Medicine techniques

11:30:12:30

Brain anatomy and molecular imaging
ILO:
1.Discuss the role of Brain Anatomy and Molecular Imaging
in relation to practice of nuclear medicine
2. Integrate the concepts discussed in relation to best

Dr. Seiichi Yamamoto
Nagoya University,Nagoya, Japan

Dr. Masanori Ichise
National Institute ofRadiological Sciences,Chiba, Japan

Dr. Satoshi Minoshima
University of Utah,
Saltlake City, USApractices of brain imaging using nuclear techniques.

12:30-14:00

Lunch Break

14:00-15:00

Radiopharmaceuticals in brain imaging: SPECT.

ILO:

Dr. Hiroshi Toyama
Fujita HealthUniversity, Nagoya,Japan

1. Recognize the significance of radiopharmaceuticals
used in SPECT brain Imaging .
2. Integrate the concepts of radiopharmaceuticals inbrain imaging within the context of best practices ofthe nuclear technology on the brain imaging
Radiopharmaceuticals in brain imaging: PET

15:00-16:00

ILO:

Dr. Tadashi Watabe,
Osaka University,Osaka, Japan

1. Summarize the Radiopharmaceuticals used in
PET/CT brain imaging
2. List examples of diseases that can be diagnosed by
FDG-PET scans.
3. Discuss principal differences between FDG and nonFDG agents in brain imaging.
16:00-17:00

SPECT and PET in stroke
ILO:

1. Discuss the utilization of SPECT and PET imaging
modalities in the evaluation of stroke
2. Determine the limitations SPECT and PET imaging
technique in stroke

End of session 1

Dr. Eku Shimosegawa
Osaka University,Osaka, Japan

Tuesday, 24 May 2016
SESSION 2
Chair:MINOSHIMA, Satoshi,
Department of Radiology, University of Washington,
1959 N.E. Pacific Street, Seattle WA,
United States of America
Shakhashiro, Abdulghani(IAEA Programme Management Officer)
09:00-10:00
Alzheimer’s Disease I
1. Understand the pathophysiology of Alzheimer’sdisease.

Dr. Kazunari Ishii
Kinki University,Osaka, Japan

2. Discuss the risk factors of Alzheimer’s disease.
3. Discuss the role of nuclear medicine imaging inAlzheimer’s dieases
10:00-11:00

PET and SPECT in Dementia (other than Alzheimer’sdisease)
1. Understand the pathophysiology of other dementias

Dr. Kenji Ishii
Tokyo Metropolitan
Institute ofGerontology, Tokyo,Japan

2. Discuss the risk factors
3. Discuss the role of nuclear medicine imaging in otherdementias
11:00:12:00

Case Presentation: Dementia
ILO:
Discuss the role of Brain Imaging using actual cases forimage interpretation and its relevance in clinicalpractice

GIESEL, Frederik
MINOSHIMA, Satoshi
Local Experts

12:00-14:00

Lunch Break

14:00-15:00

Seizures
1. Understand the pathophysiology of seizures
2. Discuss the risk factors

Dr. Daichi Sone
National Center of
Neurology andPsychiatry, Tokyo,Japan

3. Discuss the role of nuclear medicine imaging inseizures
15:00-16:00

Brain Tumour
1. Understand the pathophysiology/ classification ofdifferent brain tumorus
2. Discuss the risk factors
3. Discuss the role of nuclear medicine imaging in brain
tumours16:00-17:00

Case Presentation: Brain Tumour
Discuss the role of Brain Imaging using actual cases forimage interpretation and its relevance in clinicalpractice

End of session 2

GIESEL, Frederik
University HospitalHeidelberg
Department ofNuclear Medicine
Clinic of Radiology
69120 Heidelberg
Germany

Dr. Kenji Hirata
Hokkaido University,Sapporo, Japan

Wednesday, 25 May 2016
SESSION 3
Chair:
GIESEL, Frederik
University Hospital Heidelberg
Department of Nuclear Medicine Clinic of Radiology
69120 Heidelberg
Germany
9:00-10:00
Movement Disorder

1. Understand the pathophysiology of Movement
disorders.

Dr. Hiroshi Matsuda
National Center ofNeurology andPsychiatry, Tokyo,
Japan

2. Discuss the utilization of nuclear medicine imaging
modalities in the evaluation of movement disorders
10:00-11:00

Case Presentation: Parkinson’s Disease and Related
Disorders
ILO:

Dr. Etsuko Imabayashi
National Center ofNeurology andPsychiatry, Tokyo,
Japan

Discuss the role of Brain Imaging using actual cases forimage interpretation and its relevance in clinicalpractice
11:00-12:00

Pediatric Nuclear Medicine
ILO:
1. Understand the pathophysiology/ classification ofdifferent paediatric brain tumours and neurologicaldisorders
2. Discuss the role of nuclear medicine imaging inpaediatric brain imaging

12:00-14:00

Lunch BreakDr. Mayuki Uchiyama
The Jikei University
School of Medicine,Tokyo, Japan

14:00-15:00

Brain Trauma

Dr. Toru Shiga
Hokkaido University,
Sapporo, Japan

ILO:
Discuss the role of nuclear medicine imaging in brain
trauma
16:00-17:00

Brain Death

Dr. Toshimitsu
MomoseThe University ofTokyo, Tokyo, Japan

ILO:
Discuss the role of nuclear medicine imaging
techniques in brain death imaging

End of session 3

Thursday 26 May 2017
SESSION 4:
Chair:MINOSHIMA, Satoshi,
Department of Radiology,
University of Washington,
1959 N.E. Pacific Street, Seattle
WA, United States of America

09:00-12:00

Case presentation (including report writing and group
discussion):
ILO:
1. Describe appropriate ways of report writing inneurological cases

Dr. Mitsuaki Tatsumi
Osaka University,
Osaka, Japan
Dr. Tadashi Watabe
Osaka University,
Osaka, Japan

2. Discuss the role of Brain Imaging using actual cases
for image interpretation and its relevance in clinicalpractice
12:00-14:00

Lunch Break

14:00-17:00

Parametric image analysis of brain images (includingsoftware practice):
ILO:
1. Enumerate and discuss the different Parametricimage analysis used in brain imaging

END OF SESSION 4

Dr. Hiroki Kato
Osaka University,Osaka, Japan
Dr. Tadashi Watabe
Osaka University,Osaka, Japan

Friday, 27 May 2015
SESSION 5
CHAIR:
GIESEL, Frederik
University Hospital Heidelberg
Department of Nuclear Medicine Clinic of Radiology
69120 Heidelberg
Germany
9:00-10:00

SPECT and PET in Psychiatry
ILO:
1. Understand the pathophysiology/ classification ofdifferent psychiatric cases in relation to brain imaging

Dr. Tetsuya Suhara
National Institute ofRadiologicalSciences, Chiba,Japan

2. Discuss the role of nuclear medicine imaging inpsychiatry
10:00-11:00

Nuclear Medicine In New Drug Development
ILO:

Dr. Jun Hatazawa
Osaka University,Osaka, Japan

1. Describe and discuss new drug developments inrelation to nuclear medicine imaging
2. Discuss the role of Brain Imaging using actual cases
for image interpretation and its relevance in clinicalpractice
11:00-11:30

Future application of Brain Nuclear Medicine
ILO:
1.Describe and explain future application of brain
imaging using nuclear medicine techniques

Dr. Satoshi
Minoshima,
University of Utah,
USA2.Explore possibilities on how these newer
technologies will have a positive impact on nuclear
medicine practice
11:30-12:00

Closing Remarks
Post course evaluation

Pascual, Thomas(Technical Officer,IAEA)
Shakhashiro,
Abdulghani(IAEA ProgrammeManagementOfficer)
Prof. Jun Hatazawa
Course Director